Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05062395 · ClinicalTrials.gov registry record
Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 13
- Enrollment target
NCT05062395: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT05062395 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05062395 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
This study evaluates positron emission tomography for the diagnosis of immune checkpoint inhibitor-related myocarditis. Immune checkpoint inhibitors have shown promising results in various malignancies however, several immune related adverse events have been described of which myocarditis carries the highest reported mortality. Diagnostic procedures, such as positron emission tomography, help find and diagnose myocarditis and provide functional or disease activity information as opposed to the largely structural/anatomic information.
Interventions
- PROCEDURE Computed Tomography
- PROCEDURE Positron Emission Tomography
- OTHER Fludeoxyglucose F-18
- OTHER Low Carbohydrate High Fat Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-03-30 |
| Est. Completion | 2023-04-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05062395
The ClinicalTrials.gov registry entry for NCT05062395 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Computed Tomography is the first listed.
NCT05062395 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05062395 about?
NCT05062395 is a clinical study titled "Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis". This study evaluates positron emission tomography for the diagnosis of immune checkpoint inhibitor-related myocarditis. Immune checkpoint inhibitors have shown promising results in various malignancies however, several immune related adverse events have been described of which myocarditis carries th...
What is the current status of trial NCT05062395?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2021-03-30. Estimated completion is 2023-04-04.
What interventions are being tested in trial NCT05062395?
The interventions under investigation include: Computed Tomography (PROCEDURE), Positron Emission Tomography (PROCEDURE), Fludeoxyglucose F-18 (OTHER), Low Carbohydrate High Fat Diet (OTHER).
Who is sponsoring clinical trial NCT05062395?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.